SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Biotricity, Inc. (BTCY) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+1381.9%).
- 分析师共识目标价 $4.00 (+1381.9% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 46/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BTCY
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.42
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.55
每股账面价值$0.00
每股营收$0.64
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$4.00 (+1381.9%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-1.42 |
$0.00 |
$-5.19M |
- |
| 2017 |
$-1.81 |
$0.00 |
$-7.81M |
- |
| 2018 |
$-1.72 |
$0.00 |
$-8.62M |
- |
| 2019 |
$-1.54 |
$398.2K |
$-8.59M |
-2157.7% |
| 2020 |
$-1.85 |
$1.42M |
$-11.07M |
-780.6% |
| 2021 |
$-2.48 |
$3.38M |
$-15.49M |
-457.7% |
| 2022 |
$-3.85 |
$7.65M |
$-29.13M |
-380.8% |
| 2023 |
$-2.15 |
$9.64M |
$-18.66M |
-193.6% |
| 2024 |
$-1.66 |
$12.06M |
$-14.09M |
-116.8% |
| 2025 |
$-0.55 |
$13.79M |
$-8.42M |
-61.1% |
